Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 1,568,841 | 1,534,141 | -34,700 | $82.52M | $144.44M | 29.40% | +$61.92M |
| Stoke Therapeutics, Inc.(STOK) | 5,404,674 | 5,404,674 | 0 | $61.34M | $109.88M | 22.37% | +$48.54M |
| GH Research PLC(GHRS) | 6,746,951 | 8,601,189 | +1,854,238 | $82.25M | $104.31M | 21.23% | +$22.07M |
| Protagonist Therapeutics Inc | 733,014 | 700,014 | -33,000 | $40.51M | $46.50M | 9.47% | +$5.99M |
| Cullinan Therapeutics, Inc.(CGEM) | 4,400,842 | 5,766,090 | +1,365,248 | $33.14M | $34.19M | 6.96% | +$1.05M |
| C4 Therapeutics, Inc.(CCCC) | 7,098,133 | 7,098,133 | 0 | $10.15M | $15.76M | 3.21% | +$5.61M |
| TScan Therapeutics, Inc.(TCRX) | 7,857,347 | 7,857,347 | 0 | $11.39M | $14.30M | 2.91% | +$2.91M |
| Precision BioSciences, Inc.(DTIL) | 1,036,051 | 1,042,596 | +6,545 | $4.35M | $5.76M | 1.17% | +$1.40M |
| ADC Therapeutics SASHS(ADCT) | 0 | 1,325,848 | +1,325,848 | $0 | $5.30M | 1.08% | +$5.30M |
| Passage Bio, Inc.(PASG) | 0 | 623,704 | +623,704 | $0 | $5.01M | 1.02% | +$5.01M |
| Denali Therapeutics Inc.(DNLI) | 0 | 261,687 | +261,687 | $0 | $3.80M | 0.77% | +$3.80M |
| iBio, Inc.(IBIO) | 1,538,573 | 1,055,897 | -482,676 | $1.17M | $874.1K | 0.18% | -$300.0K |
| Allogene Therapeutics Inc | 11,057,009 | 546,119 | -10,510,890 | $12.49M | $677.2K | 0.14% | -$11.82M |
| Design Therapeutics, Inc.(DSGN) | 65,954 | 65,954 | 0 | $222.3K | $496.6K | 0.10% | +$274.4K |
| Assembly Biosciences Inc | 10,366 | 0 | -10,366 | $187.8K | $0 | — | -$187.8K |
| Neuphoria Therapeutics Inc | 45,806 | 0 | -45,806 | $325.2K | $0 | — | -$325.2K |
| Passage Bio, Inc.(PASG) | 9,256,953 | 0 | -9,256,953 | $3.71M | $0 | — | -$3.71M |
| Upstream Bio, Inc.(UPB) | 219,247 | 0 | -219,247 | $2.41M | $0 | — | -$2.41M |